Healthcare Industry News:  SceptreC 

Devices Cardiology Radiology

 News Release - May 31, 2006

Hitachi's SceptreC(TM) Provides Cardiac PET Alternative at Annual Society of Nuclear Medicine Meeting

TWINSBURG, Ohio--(HSMN NewsFeed)--May 31, 2006--Hitachi Medical Systems America Inc. (HMSA) will feature the SceptreC Cardiac PET system at the annual Society of Nuclear Medicine (SNM) meeting June 3-7, 2006 in San Diego, California. Specifically configured for cardiac PET, SceptreC allows the utilization of both Rubidium-82 for myocardial perfusion and 18-FDG for myocardial viability procedures.

"Whole-body PET/CT offers significant throughput advantages for Oncology." states Raymond Wtulich, PET & PET/CT Product Manager for HMSA. "However, in Cardiac imaging only one bed position is required for a stress or rest acquisition making dedicated PET a comparable throughput solution at a dramatically lower cost for both equipment and service" continues Wtulich.

The SceptreC features fast acquisition times providing an efficient assessment of both stress and rest myocardial perfusion in under forty minutes. SceptreC is optimized with 3D Pico electronics to provide high-count rate capability and includes the Emory Cardiac Software PETtools(TM) for cardiac quantification to deliver an alternative solution to SPECT or PET/CT for myocardial perfusion and viability studies.

Hitachi Medical Systems America, Inc. markets premium and high performance magnetic resonance imaging systems of Hitachi Medical Corporation, Tokyo, Japan. These include the Echelon(TM) 1.5T MR system, AIRIS® Elite advanced mid-field open MR system and the Altaire® high-field performance Open MR system. HMSA established a leadership position in the medical industry with over 1,500 Open MRI systems installed across the US and provides multi-modality solutions to include the Sceptre® line of PET and PET/CT, the CXR(TM) line of multi-slice CT systems, and the HI VISION(TM) line of ultrasound systems.

Hitachi, Ltd., (NYSE:HIT ; TOKYO:6501 ), headquartered in Tokyo, Japan, is a leading global electronics company with approximately 356,000 employees worldwide. Fiscal 2005 (ended March 31, 2006) consolidated sales totaled 9,464 billion yen ($80.9 billion). The company offers a wide range of systems, products and services in market sectors including information systems, electronic devices, power and industrial systems, consumer products, materials and financial services. For more information on Hitachi, please visit the company's website at

Source: Hitachi Medical Systems

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.